Develay et al.
from the filtrate under reduced pressure. The residue was purified
by chromatography on silica gel using a gradient elution. The
monoaminated compound 1-iodo-3-(1-pyrazolyl)-benzene (pre-6)
eluted first at 80% hexane/20% diethyl ether, followed by HL1, a
pale yellow oil, at 55% hexane/45% diethyl ether (255 mg, 81%).
HL3. From 1,3-dibromo-5-(4-methoxyphenyl)-benzene (240 mg,
0.74 mmol), giving HL4 (55 mg, 25% over two steps), eluting at
1
70% hexane/30% diethyl ether. H NMR (CDCl3, 200 MHz): δ
8.07 (2H, d, 3J ) 2.5, H5pz), 8.02 (1H, t, 4J ) 2.0, H2), 7.84 (2H,
4
3
3
d, J ) 2.0, H4), 7.77 (2H, d, J ) 1.5, H3pz), 7.60 (2H, d, J )
1
4
8.0, Hb), 7.29 (2H, d, J ) 8.0, Ha), 6.52 (2H, dd, J ) 2.5, 1.5,
H4pz), 2.42 (3H, s, CH3). MS (ES+): m/z 301 (M + H+).
HL4. From 1,3-dibromo-5-(4-methoxyphenyl)-benzene (300 mg,
0.88 mmol), giving HL4 (48 mg, 15% over two steps), eluting at
3
3
Data for pre-6: H NMR (CDCl3, 200 MHz): δ 8.07 (1H, t, J )
2.0, H2), 7.85 (1H, d, 3J ) 2.5, H5pz), 7.70 (1H, d, 3J ) 1.5, H3pz),
3
7.60 (2H, overlapping m, H4 and H6), 7.12 (1H, t, J ) 8.0, H5),
6.43 (1H, dd, 3J ) 2.5, 3J ) 2.0, H4pz). MS (ES+): m/z 271.0 (M
+ H+). Data for HL1: 1H NMR (CDCl3, 500 MHz): δ 8.12 (1H, t,
1
70% hexane/30% diethyl ether. H NMR (CDCl3, 300 MHz): δ
3
3
4J 2.0, H2), 8.03 (2H, d, J ) 2.5, H5pz), 7.76 (2H, d, J ) 1.5,
H3pz), 7.65 (2H, dd, 3J ) 8.0, 4J ) 2.0, H4), 7.54 (1H, t, 3J ) 8.0,
H5), 6.51 (2H, m, H4pz). 13C NMR (CDCl3, 500 MHz): 141.7
(C3pz), 141.4 (C1), 130.7 (C5), 127.2 (C5pz), 116.8 (C4), 110.2 (C2),
108.3 (C4pz). MS (EI+): m/z 210 (M+).
8.04 (2H, d, 3J ) 2.5, H5pz), 7.97 (1H, t, 4J ) 2.0, H2), 7.80 (2H,
4
3
3
d, J ) 2.0, H4), 7.76 (2H, d, J ) 1.5, H3pz), 7.61 (2H, d, J )
9.0, Hb), 6.98 (2H, d, J ) 9.0, Ha), 6.52 (2H, appears as t, J )
2.0, H4pz), 3.84 (3H, s, CH3). MS (ES+): m/z 317 (M + H+).
HL5. From 1,3-dibromo-5-(4-(dimethylamino)phenyl)-benzene
(255 mg, 0.72 mmol), giving HL5 (33 mg, 14% over two steps),
3
3
1,3-Bis(1-pyrazolyl)-5-methyl-benzene HL2. Step 1. A mixture
of 1,3-dibromo-5-methyl-benzene (680 mg, 2.7 mmol), sodium
iodide (1.6 g, 10.9 mmol), copper(I) iodide (52 mg, 0.27 mmol),
and N,N′-dimethylethylenediamine (48 mg, 0.54 mmol) in toluene
(3 mL) was degassed, and then heated at reflux with vigorous
stirring for 48 h. After cooling, the solvent was removed under
reduced pressure, and the residue was taken up into a mixture of
dichloromethane (50 mL) and aqueous sodium hydroxide (1 M,
30 mL). The organic phase was separated, washed with water, dried
over anhydrous MgSO4, and evaporated to dryness, to give a
mixture of 1,3-di-iodo-5-methylbenzene, 1-iodo-3-bromo-5-meth-
ylbenzene, and the starting material dibromotoluene. The com-
pounds are not readily separable by chromatography: it proves more
straighforward to use the crude mixture directly in Step 2. 1H NMR
for the di-iodo product (CDCl3, 300 MHz): δ 7.85 (1H, s, H2),
7.48 (2H, s, H4), 2.25 (3H, s, CH3).
1
eluting at 60% hexane/40% diethylether. H NMR (CDCl3, 200
MHz): δ 8.06 (2H, d, J ) 2.5, H5pz), 7.94 (1H, t, J ) 2.0, H2),
3
4
7.83 (2H, d, 4J ) 2.0, H4), 7.77 (2H, d, 3J ) 1.5, H3pz), 7.62 (2H,
3
3
d, J ) 9.0, Hb), 6.81 (2H, d, J ) 9.0, Ha), 6.52 (2H, appears as
t,3J ) 2.0, H4pz), 3.03 (6H, s, NMe2). MS (ES+): m/z 330 (M+H+).
Mixed Pyridyl-Pyrazole Ligands HL6-8. HL6. The precursor
1-bromo-3-(1-pyrazolyl)-benzene, pre-6, (130 mg, 0.48 mmol),
2-tributylstannylpyridine (266 mg, 0.72 mmol), Pd(PPh3)2Cl2 (6 mg,
0.014 mmol), and LiCl (64 mg, 1.5 mmol) were combined in
toluene (5 mL) and degassed by freeze-pump-thaw (5 cycles).
The mixture was heated at reflux with stirring for 24 h. After cooling
to room temperature, a saturated aqueous solution of KF (10 mL)
was added and stirring continued for 1 h. The insoluble residue
formed was removed by filtration and washed with toluene. The
combined organic solution was evaporated to dryness under reduced
pressure, giving a brown residue, which was taken up into
dichloromethane (75 mL) and washed with NaHCO3(aq) (1 M, 3 ×
50 mL). The organic layer was separated, dried over anhydrous
potassium carbonate, and the solvent removed under reduced
pressure. The brown residue was purified by chromatography on
silica gel, gradient elution from hexane to 70% hexane/30% diethyl
ether, giving HL6 as a colorless oil (48 mg, 45%).
Step 2. The crude mixture from Step 1 was subject to the copper-
catalyzed amination with pyrazole, as described for HL1. After
workup, the crude mixture was purified by column chromatography
on silica using a gradient elution. The side product 1-bromo-3-(1-
pyrazolyl)-5-methyl-benzene (pre-7) eluted first at 80% hexane/
20% diethyl ether, followed by 1,3-bis(1-pyrazolyl)-5-methyl-
benzene, HL2 at 60% hexane/40% diethyl ether (80%). Data for
pre-7: 1H NMR (CDCl3, 300 MHz): δ 7.89 (1H, d, 3J ) 2.5, H5pz),
3
1H NMR (CDCl3, 500 MHz): δ 8.70 (1H, d, J ) 5.0, H6py),
3
7.71 (1H, d, J ) 1.5, H3pz), 7.67, 7.48, 7.24 (each 1H, s, H2, H4
8.37 (1H, t, 4J ) 2.0, H2), 8.05 (1H, d, 3J ) 2.0, H5pz), 7.90 (1H,
d, 3J ) 7.5, H4 or H6), 7.77 (4H, overlapping m, H3pz, H3py, H4py,
and H6), 6.47 (1H, m, H4pz), 2.39 (3H, s, CH3). ES (MS+) 237/
239 (M + H+ 79/81Br). Data for HL2: 1H NMR (CDCl3, 300 MHz):
δ 7.99 (2H, d,3J ) 2.5, H5pz), 7.85 (1H, t, 4J ) 2.0, H2), 7.73 (2H,
d, 3J ) 1.5, H3pz), 7.46 (2H, t, 4J ) 2.0, H4), 6.48 (2H, m, H4pz),
2.47 (3H, s, CH3). MS (ES+): m/z 225 (M + H+), 247 (M + Na+).
13C NMR (CDCl3, 126 MHz): δ 141.5 (C3pz), 141.2 (Cq), 141.1
(Cq), 127.2 (C5pz), 117.7 (C4), 108.1 (C4pz), 107.4 (C2), 21.9 (CH3).
Anal. Calcd for C13H12N4: C, 69.6; H, 5.5; N, 25.0%. Found: C,
69.6; H, 5.4; N, 25.0%.
3
3
and H6 or H4), 7.55 (1H, t, J ) 7.5, H5), 7.26 (1H, dd, J ) 7.0,
3
3J ) 5.0, H5py), 6.49 (dd, J ) 2.5,3J ) 1.5, H4pz).
13C{1H} NMR (CDCl3;): δ 156.6 (C2py), 150.0 (C6py), 141.4
(C5pz), 141.0, 140.9, 137.1 (C4py), 130.1 (C5py), 127.2 (C3pz),
125.0 (C2′), 122.9, 120.9 (C3py), 119.9, 117.8, 107.9 (C4pz). MS
(ES+): m/z 222 [M + H+], 244 [M + Na+]. HRMS (ES+): m/z
222.0998 [M + H+]; calcd for C14H12N3, 222.1001.
HL7 and HL8, both colorless oils, were prepared similarly: HL7
from pre-7, eluting at 75% hexane/25% diethyl ether in a yield of
74%; HL8 from pre-8, eluting at 70% hexane/30% diethyl ether,
in 35% yield.
Data for pre-8 and HL2M, the 3,5-dimethylpyrazolyl analogues
of pre-7 and HL2, are provided in the Supporting Information.
1,3-Bis(1-pyrazolyl)-5-p-substituted-aryl-benzenes HL3-HL5.
Step 1. The preparation of the 1,3-dibromo-5-aryl-benzenes was
accomplished by cross-coupling with the appropriate aryl boronic
acid using the procedure described previously.11
Step 2. The 1,3-dibromo-5-aryl-benzene was subject to copper-
catalyzed bromo-iodo exchange using the procedure described
above for the synthesis of HL2, step 1. The crude product, consisting
primarily of the di-iodinated aromatic, was used directly in the next
step without purification at this stage.
Step 3. The crude 1,3-di-iodo-5-aryl-benzene was subject to
copper-catalyzed amination with pyrazole using the procedure
described above for step 2 of the synthesis of HL2.
Data for HL7. H NMR (CDCl3, 300 MHz): δ 8.70 (1H, d, J
1
3
) 5.0, H6py), 8.10 (1H, s, H2), 8.04 (1H, d, J ) 2.5, H5pz), 7.77
3
(4H, m, H3pz, H3py, H4py, and H6 or H4), 7.63 (1H, s, H4 or H6),
7.27 (1H, m overlapping CHCl3, H5py), 6.48 (1H, m, H4pz), 2.50
(3H, s). M + H+: cal 235.28 mes 236.1. HRMS (ES+) m/z:
236.1190 [M+H+]; calcd for C15H14N3, 236.1188.
Data for HL8. H NMR (CDCl3, 500 MHz): δ 8.69 (1H, m,
1
H6py), 7.84 (1H, s, H6), 7.80 (1H, s, H2), 7.74 (2H, m, H3 and
H4py), 7.32 (1H, s, H4), 7.26 (1H, m, H5py), 6.00 (1H, s, H4pz),
2.48 (3H, s, CH3aryl), 2.34 (3H, s, CH3 pz), 2.31 (3H, s, CH33pz).
5
13C{1H} NMR (CDCl3): δ 156.9 (C2py), 149.9 (C6py), 149.2 (C3pz),
11140 Inorganic Chemistry, Vol. 47, No. 23, 2008